Today we received the formal documentation of our first US patent granted, with two more patent applications in process since we founded July 2018. We’re an R&D-intensive software as medical device company with a mission to transform radiology using machinelearning in medicalimaging to build workflow solutions, and although we disseminate knowledge through substantial research publications, protecting our IPR is key to any company building sustainable innovative technology for the future.
- Cerebriu is now certified according to ISO 13485:2016 international standard May 14, 2021
- Cerebriu Appoints Dr. Amine Korchi As Chief Medical Officer March 1, 2021
- CEREBRIU featured in WHINN TECH Talks December 22, 2020
- Cerebriu featured in Health Europa Quarterly Issue 15 November 3, 2020
- The role of MRI in stroke care with Cerebriu Apollo – Cerebriu Featured in Health Europa September 21, 2020